JQ-1 was shown to reduce the chromatin accessibility in six times as many regions in IL-1-treated FLS compared to untreated FLS, potentially affecting the binding of key transcription factors involved in RA, such as members of the NF-κB and AP-1 families [17]. Here, FOS is linked to rheumatoid arthritis.